Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
about
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitisDoxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin.Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study.Anti-inflammatory activity of ansamycins.Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.Animal models of Streptococcus pneumoniae diseaseBacterial meningitis: new therapeutic approaches.Bacterial meningitis: an update of new treatment options.Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii.Strategies to increase the activity of microglia as efficient protectors of the brain against infections.Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.Intrathecal treatment with the anti-phosphorylcholine monoclonal antibody TEPC-15 decreases neuronal damage in experimental pneumococcal meningitis.Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis.The inflammatory response and neuronal injury in Streptococcus suis meningitis.Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
P2860
Q28757559-84759852-C5B0-44AA-B297-79124F742C8FQ30540523-591A7EC3-5D87-4D49-AC05-686973C60834Q34448199-42E42132-9FC3-4DFC-8AE8-A43F74258F6FQ35755083-1D9A4153-2DCC-4F4A-A8C6-DA4BD4C37F0AQ36066223-22205C00-A6E0-4805-A56B-D3D51206A87CQ36171566-1D359130-72B4-4432-86CF-A3350B698D45Q36607421-6D39DE0B-BD5A-4E43-AFA4-E17E39FC0274Q37293669-98EFC86F-26DB-426B-AA0B-F8DBC9374E72Q38145360-488E6C47-9E07-40AD-BF5A-43DEB2FD7945Q38570487-BE0995DB-007E-43D0-B210-273FAEA8B1CAQ39584788-872EBD45-39AA-410B-8053-9A4C0C3EEBF1Q39924370-1697C7F1-65A2-44A8-8160-531B470B5E07Q42854012-B5B74F7C-3E84-4816-9800-80500C05379EQ48452268-26252618-B5C1-447B-8308-F9CCE5906B88Q48463759-21B0EF09-8708-40AC-9BEE-BBBF0D06D1E0Q55517984-ECA33D65-256D-48E2-B193-AAD44656D354Q57253129-662FEA88-F9D0-430E-9502-59484181BAAA
P2860
Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@en
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@nl
type
label
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@en
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@nl
prefLabel
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@en
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@nl
P2093
P2860
P1476
Rifampin followed by ceftriaxo ...... mparison to ceftriaxone alone.
@en
P2093
Joachim Gerber
Karin Pohl
Roland Nau
Stephanie Bunkowski
Valeska Sander
P2860
P304
P356
10.1128/AAC.47.4.1313-1317.2003
P407
P577
2003-04-01T00:00:00Z